Fund Holdings — Sarissa Capital Management LP

Total Portfolio Value:
$157.64M
Total Bought:
$1.03M
Total Sold:
$66.38M
Net Transaction:
-$65.35M
Securities
▲▼
SharesValue
Q4 2025
▲▼
Q1 2026
▲▼
Change
▲▼
Q4 2025
▲▼
Q1 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Innoviva, Inc.(INVA)2,816,0222,130,950-685,072$56.29M$49.65M31.50%-$6.64M
Ironwood Pharmaceuticals, Inc.CL A(IRWD)15,919,4359,188,635-6,730,800$53.65M$32.25M20.46%-$21.40M
Amarin Corp PlcADR1,673,3951,673,3950$23.35M$24.20M15.35%+$845.1K
Neurocrine Biosciences, Inc.(NBIX)303,151116,533-186,618$43.00M$15.35M9.74%-$27.64M
Cytokinetics, Incorporated(CYTK)396,357228,623-167,734$25.18M$15.07M9.56%-$10.12M
Lantheus Holdings, Inc.(LNTH)181,450166,919-14,531$12.08M$12.66M8.03%+$585.3K
Biohaven Ltd.(BHVN)513,184563,184+50,000$5.79M$4.76M3.02%-$1.03M
Regeneron Pharmaceuticals, Inc.(REGN)4,1904,1900$3.23M$3.24M2.05%+$3.2K
Vor Biopharma Inc.(VOR)25,39925,3990$332.2K$453.1K0.29%+$120.9K
Page 1 of 1
Sarissa Capital Management LP — 13F Holdings — Q1 2026 | TickerTrail